Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
CAR-TCR Global 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
CMC
1:27
Updates in cell and gene therapy approvals
Bruce Levine
• 27 Jan 2022
0:44
Addressing issues associated with bringing iSPC-derived MSCs to the clinic
Tony Ting
• 26 Jan 2022
1:04
The role of ARM in the cell and gene therapy industry
Michael Lehmicke
• 26 Jan 2022
1:06
Advances in cell therapies by the Cell Therapies Core
Lavakumar Karyampudi
• 27 Jan 2022
1:29
CMC challenges in cell and gene therapy manufacturing
Michael Lehmicke
• 26 Jan 2022
3:07
Addressing issues in the clinical translation of cell & gene therapies
Janet Lynch Lambert
• 26 Jan 2022
2:15
Remaining barriers to the translation of EV-based therapies
Eva Rohde
• 10 Jun 2021
4:06
Shaping the future of CMC in cell & gene therapy
Stephen Ward
• 14 Apr 2021
1:46
Regulating gene therapies: what can be learned from COVID-19?
Nicole Faust
• 9 Apr 2021
3:35
Tackling manufacturing challenges in advanced therapies
Matthew Durdy
• 9 Apr 2021
2:12
The future impact of COVID-19 on the gene therapy sector
Nicole Faust
• 9 Apr 2021
4:17
Driving the ATMP sector forward: a regulatory perspective
Ana Hidalgo-Simon
• 7 Apr 2021
2:05
The challenges of CMC in cell and gene therapies
Mike Lehmicke
• 17 Mar 2021
3:08
Accelerating commercialization in advanced therapies
Pascal Touchon
• 7 Apr 2021
